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a b s t r a c t
Elongator, a multi-subunit complex assembled by the IkappaB kinase-associated protein
(IKAP)/hELP1 scaffold protein is involved in transcriptional elongation in the nucleus as well
as in tRNA modifications in the cytoplasm. However, the biological processes regulated by
Elongator in human cells only start to be elucidated. Here we demonstrate that IKAP/hELP1
depleted colon cancer-derived cells show enhanced basal expression of some but not all
pro-apoptotic p53-dependent genes such as BAX. Moreover, Elongator deficiency causes
increased basal and daunomycin-induced expression of the pro-survival serum- and glu-
cocorticoid-induced protein kinase (SGK) gene through a p53-dependent pathway. Thus, our
data collectively demonstrate that Elongator deficiency triggers the activation of p53-
dependent genes harbouring opposite functions with respect to apoptosis.Serum- and glucocorticoid-induced # 2008 Elsevier Inc. All rights reserved.protein kinase (SGK)
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Elongator, a highly conserved complex of 6 subunits (Elp1–
Elp6), was initially identified as a complex associated with
hyperphosphorylated form of yeast RNA polymerase II and
subsequently isolated from human cells as well [1–3].
Elongator requires the scaffold IKK-associated protein
(IKAP)/ELP1/hELP1 for assembling into a functional complex
[4]. Moreover, Elp3, the catalytic subunit, harbours motifs
found in the GNAT family of histone acetyltransferases (HATs)
[5] and is essential for the ability of Elongator to target histone
H3 in vitro [2,3,6] and in vivo [7]. These observations combined
with reports showing an association of Elongator with several
nascent RNAs in yeast [8] and with the preferential recruit-
ment of Elongator to the transcribed regions of human genes
[9–11], strongly support a role for Elongator in transcriptional
elongation. Meanwhile, other reports also provided experi-
mental evidence for a role of Elongator in exocytosis and tRNA
modification [12–14]. Still and although these reports brought
significant insights regarding the biological roles of Elongator,
it is currently unclearwhether this complex harboursmultiple
functions in distinct cell compartments or whether a single
function indirectly regulates the others [15].
Loss of function models in distinct organisms helped to
decipher the Elongator-dependent pathways and their biolo-
gical relevance. Elongator yeastmutants (elp phenotypes) have
slower growth adaptation and temperature sensitivity at 39 8C
[5]. The Elongata mutants of Arabidopsis thaliana, which have
point mutations in genes coding for the yeast Elongator
subunit Elp1, Elp3 and Elp4, are characterized by reduced root
growth due to decreased cell division rate, which supports a
role for Elongator in cell proliferation in plants [16].
Consequences of impaired Elongator function in humans
are exemplified by familial dysautonomia (FD), an autosomal
recessive disease, ranging among the most frequent heredi-
tary sensory and autonomic neuropathies and characterized
by defects in the development andmaintenance of neurons of
the autonomic and sensory systems [17,18]. FD is due to a
mutation in a splice site of the IKBKAP gene, which ultimately
causes decreased expression of IKAP/hELP1 in a tissue-specific
manner [19,20]. Although the molecular and cellular mechan-
isms underlying this neuro-developmental and neurodegen-
erative genetic disorder remain largely undefined, impaired
cellmotilitymayaccount for this disease as a variety of human
cells depleted for IKAP/hELP1 harboured defects in cell
migration [11]. Thus, these studies collectively demonstrate
that impaired Elongator function causes multiple cellular
defects.
Signalling pathways triggered by DNA-damaging agents or
many other forms of cellular stress ultimately regulate gene
transcription. Whereas pre-initiation and initiation steps of
transcription involve multiple levels of regulation, there are
now accumulating evidences for transcriptional elongation
being a tightly regulated process that requires a plethora of
proteins, for example the elongation factors [21] such as TFIIF,
TFIIH, and the multi-protein complex FACT [22]. In this
context, gene transcription in response to DNA-damaging
agents relies on gene- and signal-specific elongation factors
[23]. It is currently unknown whether Elongator is required for
gene transcription in response to DNA-damaging agents andwhether Elongator deficiency impairs the ability of the other
elongating factors to properly transcribe their target genes.
In order to further characterize the Elongator-dependent
pathways and concomitantly learn more about the cellular
response to DNA-damaging agents, we generated colon
cancer-derived cells depleted for IKAP/hELP1 and showed
here that Elongator is dispensable for both basal- and
daunomycin-induced expression of some p53-dependent
genes involved in cell cycle arrest such as p21. Interestingly,
Elongator deficiency activates selected p53-dependent path-
ways, as evidenced by enhanced basal expression of BAX.
Moreover, IKAP/hELP1 depleted cells show enhanced basal
and daunomycin-induced mRNA expression of the serum-
and glucocorticoid-inducible kinase SGK through a p53-
dependent pathway. Therefore, our results represent the first
experimental evidence for a link between impaired Elongator
function and the activation of selected p53-dependent path-
ways.2. Materials and methods
2.1. Cell culture and reagents
HCT116 and p53 deficient HCT116 cells (a gift from Dr. Bert
Vogelstein, Ludwig Center for Cancer Genetics and Therapeu-
tics and Howard Hughes Medical Institute at Johns Hopkins
Kimmel Cancer Center, Baltimore, MD, USA) were maintained
in Mac Coy medium supplemented with 10% FBS and 1%
antibiotic whereas 293FT and HT29 cells were maintained in
DMEM or EMEM supplemented with 10% fetal bovine serum
(Life Technologies), 1% L-glutamine and 1% antibiotics,
respectively. Human primary fibroblasts, a gift from Dr.
Charles Lambert (Laboratory of Connective Tissues Biology,
Interdisciplinary Cluster for Applied Genoproteomics, Uni-
versity of Liege, Belgium), were cultured in DMEM supple-
mented with 10% FBS, 1% antibiotics and 1% L-glutamine.
Daunomycin hydrochloride and actinomycin D were pur-
chased from Sigma–Aldrich (Saint Louis, MO, USA). The
monoclonal anti-IKAP/hELP1 and -PARP antibodies were
purchased from BD Biosciences Pharmingen (San Jose, CA,
USA)whereas the anti-Elp3 antibodywas previously described
[11]. The anti-p21 and -BAX antibodies were from Calbiochem
(San Diego, CA, USA) whereas the anti-serine 15 phospho p53
(pp53), -p53, -FACT, -CDK9 and -a-tubulin antibodies were
from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). The
monoclonal anti-caspase 3, RhoE/Rnd3 and actin antibodies
were from Alexis (Lausen, Switzerland), Upstate (Millipore
company, Billerica, MA, USA) and Sigma (St. Louis, MO, USA),
respectively. Theses antibodies were used in Western blot
experiments, according to standard protocols.
2.2. RNAi transfection and lentiviral cell infection
RNAi oligos were synthesized by Dharmacon Research
(sequences available upon request), and were transfected
into human primary fibroblasts using calcium phosphate.
Cells were lyzed 48 h post-transfection, and anti-IKAP/hELP1
and -ELP3 Western blots were subsequently performed. The
pLL3.7 shRNA IKAP 1 and GFP lentiviral constructs were
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was generated by subcloning another IKAP sequence (avail-
able upon request) into the pLL3.7 vector. Lentiviral IKAP/
hELP1 and GFP shRNAs constructs were also generated by
subcloning the corresponding sequences into the BLOCK-iT
lentiviral RNAi expression system, according to the protocol
provided by themanufacturer (Invitrogen, Carlsbad, CA, USA).
Infected cells were subsequently selected with blasticidin
(Invivogen, San Diego, CA, USA) (10 mg/ml) to produce stably
transduced cells. Cloneswere selected based on residual IKAP/
hELP1 protein levels.
2.3. Total RNA extraction, micro-array analysis
Stably transduced IKAP/hELP1 shRNA or GFP shRNA HCT116
cells were left untreated or stimulated with daunomycin for
2 h. Those experiments were repeated with the stably
transduced IKAP/hELP1 shRNA or GFP shRNA p53 deficient
HCT116 cells in order to reach a total of 8 distinct experimental
conditions. Triplicates from each 8 experimental conditions
were subjected to total RNA extractions using the RNeasy
Minit kit (Qiagen) and the resulting total RNAs from those
triplicates were pooled. The integrity of the RNAs was
confirmed with the Agilent Bioanalyser using the RNA 6000
Nano kit (Agilent, Santa Clara, CA, USA). Double-stranded
cDNAs were generated using the Superscript II RT kit
(Invitrogen, Carlsbad, CA, USA). Subsequently, biotin-labelled
cRNA was generated using the GeneChip One-Cycle Target
Labeling kit (Affymetrix, Santa Clara, CA, USA). cRNAs were
hybridized with the Human Genome U133A array, which
harbours >22,000 probe sets (Affymetrix) targeting. Briefly,
double-stranded cDNAwas synthesized routinely from 5 mg of
total RNA primed with a poly-(dT) -T7 oligonucleotide. The
cDNAwas used in an in vitro transcription (IVT) reaction in the
presence of T7 RNA polymerase and biotin-labelled modified
nucleotides during 16 h at 37 8C. Biotinylated cRNA was
purified and then fragmented (35–200 nucleotides), together
with hybridization controls and hybridized to the micro-
arrays for 16 h at 45 8C. Using the Fluidics Station (Affymetrix),
the hybridized biotin-labelled cRNA was revealed by succes-
sive reactions with streptavidin R-phycoerythrin conjugate,
biotinylated antistreptavidine antibody and streptavidin R-
phycoerythrin conjugate. The arrays were finally scanned in
an Affymetrix/Hewlett–Packard GeneChip Scanner 3000. Data
were processed using the MAS 5.0 software (Affymetrix).
2.4. Real-time PCRs
Quantitative real-time PCRwere performedwith TaqMan 7000
SDS (Applied Biosystems, Foster City, CA, USA), using SYBR
Green detection. Primer sequences for p21 [24], B2M and IKAP/
hELP1 [11] were previously described and are available upon
request, as are the primer sequences for SGK, TNFRSF10D,
SESN2, BTG2, PKIB and BAX.
2.5. Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation assays were carried out as
previously described [11] with stably transduced IKAP/hELP1
or GFP shRNA HCT116 cells (30  106 cells/condition). Thesewere left untreated or treatedwith actinomycin D (20 nM) for 2
and/or 8 h. Sonicated extract were precleared by 1 h incuba-
tion with protein A-agarose/Herring sperm DNA (Santa Cruz/
Sigma). Immunoprecipitations were performed by incubating
the sonicated extracts with 2.5 mg of anti-HA (Y-11, negative
control), anti-p53 (FL-393) or anti-RNA polymerase II (H-224)
(Santa Cruz biotechnologies) overnight at 4 8C. Protein A-
agarosewas subsequently added andmixed for a further 1 h at
4 8C. Phenol/chloroform purified DNA fragments were ana-
lysed by real-time PCR using the SYBER Green detection. For
the normalization of the RNAPII ChIPs, the signal of a non-
coding region downstream from the albumin gene [10] was
used to compensate for possible fluctuations arising during
handling.
2.6. Caspase 3/7 cleavage and cellular viability
For the quantification of cellular apoptosis, HCT116 cells
infectedwith the pLL3.7 shRNAGFP, IKAP 1 or IKAP 2 lentiviral
constructs were seeded in 96-well plates (1  104 cells/well)
and left unstimulated or treated with actinomycin D (20 nM).
Apoptosis was measured by quantification of both caspase 3
and 7 activities, using the luminometric Caspase-Glo 3/7 assay
(Promega, Madison, USA), according to the manufacturer’s
protocol, and a Victor2 multilabel counter (PerkinElmer,
Waltham, Massachusetts, USA). For assessment of cellular
viability, HCT116 cells infected with the pLL3.7 shRNA GFP,
IKAP 1 or IKAP 2 lentiviral constructs were seeded in 96-well
plates (1  104 cells/well) and left unstimulated or treatedwith
actinomycin D (20 nM) and viability was measured using the
CellTiter-Glo Luminescent Cell Viability Assay (Promega,
Madison, USA), according to the manufacturer’s instructions.
Statistical analysis of the data was performed by one-way
ANOVA with Dunn’s multiple comparison test using Prism
4.00 Software (Graph pad, San Diego, USA), with statistical
significance accepted at P < 0.05.3. Results
3.1. IKAP/hELP1 depletion modulates gene expression in a
cell-type specific manner
We previously demonstrated that Elongator is required for the
expression of a subset of genes in HeLa cells, many of which
encoding proteins involved in cell motility. Elongator deficient
cells indeed showed defect in cell migration, as judged by
multiple assays [11]. To further characterize the Elongator-
dependent biological processes and because the links between
the signalling pathways triggered by DNA-damaging agents
and gene expression remain poorly characterized, we
hypothesized that IKAP/hELP1 deficient cells may harbour
expression defects of a subset of genes upon stimulation with
a DNA-damaging agent. To experimentally address this
hypothesis, we first generated colon cancer-derived cells
deficient for IKAP/hELP1 through RNA interference by infect-
ing HCT116 cells with a lentivirus delivering small hairpin
RNAs targeting either the IKAP/hELP1 transcript, or GFP as a
negative control (‘‘IKAP/hELP1 shRNA’’ and ‘‘GFP shRNA’’,
respectively). IKAP/hELP1 depletion in those cells did not affect
Fig. 1 – Elongator is dispensable for daunomycin-mediated
p53 phosphorylation and subsequent stabilization in colon
cancer-derived cells. (A and B) Stably infected IKAP/hELP1
and GFP shRNAs HCT116 cells were left untreated or
stimulated with daunomycin (1 mM) for 2 h. (A) Residual
IKAP/hELP1 mRNA was around 45% compared to control
cells, as assessed by quantitative real-time PCR. The
abundanceof IKAP/hELP1mRNA levels inunstimulatedGFP
shRNA HCT116 cells is set to 1 and the IKAP/hELP1 mRNA
levels in the other experimental conditions are relative to
that after normalization with beta-2-microglobulin (B2M)
levels. Data from three independent experiments
performed on three distinct infections are shown (mean
valuesW S.D.). (B) Decreased IKAP/hELP1 expression
triggers a modest p53 stabilization through serine 15
phosphorylation in both basal and daunomycin-stimulated
cells. IKAP/hELP1 shRNA and GFP shRNAHCT116 cells were
left untreated (lanes 1 and 2) or stimulated with
daunomycin for 2 h (lanes 3 and 4) and cell extracts were
subjected to anti-IKAP/hELP1, -ELP3, -serine 15 phospho
p53 (pp53) and -p53 Western blot analysis, as indicated. An
anti-a-tubulin Western blot was performed as well for
normalization purposes (bottom panel).
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resulting cells untreated or stimulated with daunomycin for
2 h. Decreased IKAP/hELP1 expression was indeed observed in
IKAP/hELP1 shRNA versus GFP shRNA cells, both at the mRNA
(Fig. 1A) and at the protein levels (Fig. 1B, compare lanes 1 and
2, top panel). Moreover, decreased IKAP/hELP1 expression
persisted in daunomycin-treated cells for up to 4 h of
treatment (Fig. 1B, top panel, compare lanes 3 and 4 and
Fig. 2). Expression of hELP3, the catalytic subunit of the
Elongator complex, was also decreased upon IKAP/hELP1
depletion (Fig. 1B, second panel from the top, compare lanes 3
and 4), in agreementwith previous observationsmade in yeast
[4] and in human cells [11]. Serine 15 of p53 is specifically
phosphorylated by DNA-damaging drugs and this post-
translational modification stabilizes p53 by preventing its
MDM2-mediated degradation [25]. Thus, we investigated to
which extent this process was impaired upon IKAP/hELP1
depletion in HCT116 cells. As expected, the unphosphorylated
and serine 15 phosphorylated forms of p53 levels were
dramatically increased upon daunomycin treatment in GFP
but also in IKAP/hELP1 shRNA cells (Fig. 1B, compare lanes 2
and 4 aswell as lanes 1 and 3, second and third panels from the
bottom). Therefore, these data indicate that Elongator defi-
ciency does not significantly impair the DNA damage-
mediated stabilization of p53 through its phosphorylation
on serine 15 in HCT116 cells.
p21 is a well known p53 target gene whose induced
expression by some DNA-damaging agents triggers a cell
cycle arrest [26,27]. Therefore, we first investigated whether
IKAP/hELP1 is somehow involved in both basal or daunomy-
cin-induced p21 expression by comparing p21 mRNA or
protein levels in IKAP/hELP1 shRNA versus GFP shRNA
HCT116 cells. Whereas daunomycin indeed induced p21
expression both at the mRNA and at the protein levels
(Fig. 2, top panels, compare lanes 2 and 5 with lanes 1 and 4),
IKAP/hELP1 depletion did not impair both basal and signal-
induced p21 expression, (Fig. 2, compare left and right panels,
respectively), at least up to 4 h of daunomycin treatment.
However, this result did not rule out the possibility that other
candidates, yet to be identified, require Elongator for their
basal or DNA-damage-induced expression.
To identify those candidates, we next subjected total RNA
extracted from untreated or daunomycin-stimulated IKAP/
hELP1 shRNA and GFP shRNA HCT116 cells to micro-array
analysis (data not shown). We hypothesized that the expres-
sion of some genes might be specifically deregulated upon
Elongator deficiency. To identify those genes, micro-array
analysis were also carried out using total RNA extracted from
IKAP/hELP1 shRNA and GFP shRNA p53 deficient HCT116 cells
as p53 plays a key role in the induction of several genes upon
daunomycin treatment. IKAP/hELP1 protein levels remained
unchanged upon daunomycin treatment in both wild type or
p53 deficient cells (Fig. 3A, top panels, compare lanes 3 and 4
and lanes 7 and 8, respectively). Some genes such as tumor
necrosis factor receptor superfamily, member 10D
(TNFRSF10D), sestrin 2 (SESN2), and BTG family member 2
(BTG2) are known to be induced by a genotoxic stress through a
p53-dependent pathway [28] and both our micro-array
analysis and our real-time PCR experiments indeed confirmed
that these genes were induced upon 2 h of daunomycintreatment in HCT116 cells (Fig. 3B, on the left). Of note, their
levels of expression did not change upon IKAP/hELP1 deple-
tion in both unstimulated or daunomycin-treated cells (Fig. 3B,
on the left). On the other hand,mRNA levels of PKIB, amember
Fig. 2 – Elongator is dispensable for the early phase of daunomycin-induced p21 expression in HCT116 cells. Stably
transduced IKAP/hELP1 shRNA (lanes 1–3) and GFP shRNA HCT116 cells (lanes 4–6) were left untreated or stimulated with
daunomycin (1 mM) for the indicated period of times. On the top, cell extracts were subjected to anti-p21, -p53, -IKAP/hELP1
and -a-tubulin Western blot analysis. At the bottom, total RNAs were extracted from untreated or daunomycin-stimulated
IKAP/hELP1 shRNA or GFP shRNA HCT116 cells as indicated and p21 mRNA levels were assessed by quantitative real-time
PCR analysis. The abundance of p21 mRNA levels in unstimulated GFP shRNA HCT116 cells is set to 1 and the p21 mRNA
levels in the other experimental conditions are relative to that after normalization with B2M levels. The figure shows the
data from three independent experiments performed on two distinct infections (mean valuesW S.D.).
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were downregulated upon hELP1/IKAP depletion in both
unstimulated or daunomycin-treated cells (Fig. 3B, on the
right). Interestingly, the decrease of gene expression upon
IKAP/hELP1 depletion was cell-type-dependent as the genes
identified in similar experiments performed in HeLa cells were
not downregulated as in IKAP/hELP1 depleted HCT116 cells
(data not shown). Even if we may expect Elongator to play
identical roles in distinct cell types, the identity of the genes
whose expression is Elongator-dependent differs fromone cell
type to another, as previously discussed [11].
We previously reported a list of gene candidates whose
expression was enhanced upon IKAP/hELP1 depletion in HeLa
cells [11], suggesting that Elongator may also inhibit gene
expression through yet unclear but potentially indirect
mechanisms. Thus, we next focused our attention on the
candidates whose expression was induced upon IKAP/hELP1
depletion in HCT116 cells. Interestingly, a significant number
of them included candidates known to be regulated by p53.
Among them were BARD1, BAX, SGK, DUSP4 and NR2F2
(Fig. 3C). As expected these p53-dependent genes [29–31] were
no longer induced upon IKAP/hELP1 depletion in p53 deficient
HCT116 cells (Fig. 3C). Taken together, our data provide a linkbetween Elongator deficiency and the induction of some but
not all p53-dependent genes.
3.2. IKAP/hELP1 inhibits basal and daunomycin-induced
SGK expression in HCT116 cells and in untransformed
fibroblasts
Among the genes whose basal expression is induced upon
IKAP/hELP1 depletion, we found SGK and this finding was
indeed confirmed by real-time PCR analysis) (Fig. 4A). Because
SGK expression is p53-inducible in some cell types [32], we
next determined whether the enhanced SGK expression seen
upon Elongator deficiency also occurred in p53 deficient
HCT116 cells. Interestingly, SGK mRNA levels were not
induced in daunomycin-treated HCT116 cells lacking p53
and IKAP/hELP1 depletion did not cause increased SGK
expression in such cells (Fig. 4A). Therefore, our results
suggest that enhanced SGK expression seen in Elongator
deficient cells occurs through a p53-dependent pathway in
colon cancer-derived cells.
We next explored whether a similar observation can be
made in another cell typewhere p53 is functional and selected
normal diploid human fibroblasts. Two distinct RNAi
Fig. 3 – Elongator deficiency differentially regulates the expression of basal and daunomycin-induced genes in HCT116 cells
and triggers the upregulation of selected p53-dependent genes. (A) Establishment of IKAP/hELP1 depleted wild type or p53
deficient HCT116 cells. Stably transduced IKAP/hELP1 shRNA and GFP shRNA wild type (lanes 1–4) or p53 deficient isogenic
HCT116 cells (lanes 5–8) were left untreated or stimulated with daunomycin (1 mM) for 2 h. Protein cell extracts were
subjected to anti-IKAP/hELP1, -p53 and -a-tubulin Western blot analysis. (B) IKAP/hELP1 depletion causes impaired PKIB
expression but not basal and daunomycin-induced expression of several p53-inducible target genes. mRNA levels of
TNFRSF10D, SESN2, BTG2 and PKIB were assessed and represented as described in Fig. 2, using total RNAs isolated from
untreated or daunomycin-stimulated IKAP/hELP1 shRNA or GFP shRNA HCT116 cells as indicated. The figure shows the
data from three independent experiments generated from three independent infections (mean valuesW S.D.). (C) IKAP/
hELP1 depletion causes enhanced expression of selected p53 target genes. Micro-array analysis was performed using total
RNAs isolated from untreated stably transduced IKAP/hELP1 shRNA or GFP shRNA wild type or p53 deficient HCT116 cells
as indicated. The p53-dependent genes whose expression is increased in IKAP vs. GFP shRNA wild type or p53 deficient
HCT116 cells are listed (left and right columns, respectively). Values represent the fold inductions in IKAP vs. GFP cells.
Change P values are mentioned as well.
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Fig. 4 – IKAP/hELP1 depletion enhances basal and daunomycin-induced SGK expression through a p53-dependent pathway.
(A) Enhanced basal and daunomycin-induced SGK expression upon IKAP/hELP1 depletion in HCT116 cells. Stably
transduced IKAP/hELP1 shRNA and GFP shRNA wild type or p53 deficient HCT116 cells were left untreated or stimulated
with daunomycin (1 mM) for 2 h. Total RNAs from these cells were extracted and SGK mRNA levels were assessed by
quantitative real-time PCR. The abundance of SGK mRNAs in unstimulated GFP shRNA cells was set to 1 and SGK mRNA
levels in the other conditions were relative to that after normalization with B2M levels. The figure shows the data from
three independent experiments generated from 3 (WT p53 cells) or 2 (p53S/S cells) independent lentiviral infections (mean
valuesW S.D.). (B) Enhanced basal mRNA SGK expression in human primary fibroblasts depleted for IKAP/hELP1.
Untransformed human fibroblasts were transfected with a GFP RNAi or with two distinct RNAis targeting the IKAP/hELP1
transcript (‘‘IKAP1’’ and ‘‘IKAP2’’) and left untreated or stimulated 48 h later with daunomycin (1 mM) for the indicated
periods of time. On the top, protein cell extracts were subjected to anti-IKAP/hELP1, -p53 and -a-tubulin Western blot
analysis. At the bottom, total RNAs from ‘‘GFP’’, ‘‘IKAP1’’ or ‘‘IKAP2’’ fibroblasts subsequently left untreated or stimulated
with daunomycin (1 mM) for 2 h were extracted and SGK mRNA levels were assessed by quantitative real-time PCR. The
data are represented as described before. The figure shows the data from three independent experiments performed with
three distinct RNAi transfections (mean valuesW S.D.). (C) Lack of dramatic increased SGK mRNA expression in IKAP/hELP1
depleted HT29 cells. Colon cancer-derived cells HT29 cells were infected with the pLL3.7 shRNA GFP or IKAP2 lentiviral
construct and protein cell extracts were subjected to anti-IKAP/hELP1 and -a-tubulin Western blot analyses to confirm
IKAP/hELP1 depletion (on the left). On the right, pLL3.7 shRNA GFP or IKAP infected HT29 cells were left untreated or
stimulated with daunomycin (1 mM) for 2 h and SGK mRNA levels were assessed by quantitative real-time PCR using total
RNAs extracted from these cells. The figure shows the data from two independent experiments performed on two distinct
infections (mean values W S.D.). (D) RNA polymerase II recruitment on the TATA box of the SGK promoter is not deregulated
upon IKAP/hELP1 deficiency. On the top, schematic representation of both the SGK and p21 genes. Exons are depicted by
boxes whereas the transcription initiation site (+1) and the initial ATG (vertical arrows) are also indicated. The localization
of the primers used for ChIP analysis is illustrated by horizontal arrows and their position are indicated in kilobase relative
to the transcription initiation site. The potential p53 binding site on the SGK gene was identified using the GENOMATIX–
Matinspector program as was the previously identified p53 binding site on the p21 gene. At the bottom, ChIP assays using
an anti-RNA polymerase II antibody were performed with stably transduced IKAP/hELP1 shRNA and GFP shRNA HCT116
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Fig. 5 – IKAP/hELP1 depletion does not alter actinomycin D-
mediated RhoE/Rnd3 expression. HCT116 cells were
infected with the pLL3.7 shRNA GFP, IKAP 1 [11] or the
IKAP 2 lentiviral construct (which targets another
sequence of the IKAP/hELP1 transcript) and the resulting
infected cells were left untreated or stimulated with
actinomycin D (20 nM) for the indicated periods of time.
Anti-RhoE/Rnd3, -p53, -IKAP/hELP1 and -a-tubulin
Western blot analysis were carried out on the cell extracts.
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IKAP/hELP1 transcript. As expected, p53 expression was
induced upon stimulation with daunomycin (Fig. 4B, compare
lanes 1–3 with lanes 7–9). Moreover and in agreement with
results obtained in HCT116 cells, SGK mRNA levels were also
enhanced upon IKAP/hELP1 depletion, especially in fibroblasts
targeted with the ‘‘IKAP 2’’ RNAi sequence (Fig. 4B) which
actually caused a more dramatic IKAP/hELP1 depletion
compared to the ‘‘IKAP1’’ RNAi sequence (Fig. 4B, top panel,
compare lane 1 with lanes 2 and 3). Of note, SGK expression
wasnot inducedupondaunomycin treatment (Fig. 4B) and this
observation may reflect the inability of p53 to induce SGK
expression in fibroblasts, as previously reported in the Rat-2
fibroblasts-derived cell line [32]. Finally, SGK expression was
not daunomycin-inducible in colon cancer-derived HT29 cells
where p53 is not functional and SGK expression wasmodestly
enhanced in Elongator deficient cells despite robust IKAP/
hELP1 depletion (Fig. 4C). Thus, we identified SGK as a gene
whose expression is enhanced upon Elongator deficiency in
several cell types and this pathway requires wild type p53.
Because the transcriptional elongation of genes induced
upon DNA-damaging agents involves elongation factors
whose recruitment occurs in a gene and signal-specific
manner, we next explored whether IKAP/hELP1 depletion
impaired CDK9 and FACT levels of expression, as both of them
are recruited to distinct regions of the p21 locus in response to
DNA damage [23]. IKAP/hELP1 depletion did not affect FACT
and CDK9 levels of expression, both in untreated and
daunomycin-stimulated HCT116 cells (Fig. S1, on the left,
second and third panels from the top, compare lanes 1–3 with
lanes 4–6). A similar conclusion was raised in p53 deficient
HCT116 cells (Fig. S1, on the right). Moreover, preliminary data
excluded a differential recruitment of CDK9 or FACT to the SGK
locus upon Elongator deficiency, as evidenced by ChIP assays
(data not shown). Therefore, the deregulated SGK expression
seen in IKAP/hELP1 depleted HCT116 cells occurs in a CDK9
and FACT-independent pathway.
p53 induces gene transcription through binding to a well-
defined consensus sequence [33]. Thus, we next investigated
whether the p53-dependent SGK upregulation seen upon
Elongator deficiency requires a direct binding of p53 to the SGK
promoter. We took advantage of the GENOMATIX software
(Matinspector) to identify potential p53-binding sequence
within a 5000 bp long region upstream of the transcriptional
initiation site. One potential p53-binding site was identified on
the SGK promoter, as was the previously characterized p53-
binding sequence found on the p21 promoter (Fig. 4D). Still, we
did not see any p53 recruitment on the SGK promoter by ChIP
analysis on this sitewhereas such p53 recruitmentwas indeed
observed upon actinomycin D stimulation on the p21
promoter (data not shown). In order to see whether the SGK
induction observed upon IKAP/hELP1 depletion occurs at the
transcriptional level, we next investigated whether an
enhanced recruitment of RNA polymerase II could underliecells which were left untreated or stimulated with actinomycin
derived from the nearest region of the transcription initiation si
recruitment of RNA polymerase II in untreated GFP shRNA cells
relative to that after normalization with a non-coding region. T
experiments performed with two distinct infections (mean valuthe upregulated SGK expression seen in IKAP/hELP1 depleted
cells. As expected, enhanced RNA polymerase II recruitment
on the p21 promoter was observed in actinomycin D-
stimulated shRNA GFP HCT116 cells, as previously described
[23]. Of note, such recruitment was further enhanced in IKAP/
hELP1 shRNA HCT116 cells stimulated for 8 h with this DNA-
damaging drug which means that p21 induction may be
positively regulated upon Elongator deficiency in later times
(Fig. 4D, right panel at the bottom). On the other hand, no
significant changes for RNA polymerase II recruitment on the
SGK promoter was observed upon Elongator deficiency
(Fig. 4D, left panel at the bottom). Taken together, our results
suggest that Elongator deficiency causes SGK upregulation
through a transcriptional initiation-independent pathway.
Similarly to SGK, RhoE/Rnd3 is another p53-dependent and
pro-survival gene induced upon DNA damage [34]. Becausewe
systematically noticed that prolonged daunomycin treat-
ments restored IKAP/hELP1 expression in IKAP/hELP1 shRNA
cells (data not shown), we selected actinomycin D as another
DNA-damaging agent. Therefore, we next explored whether
RhoE/Rnd3 induction in actinomycin D-treated cells was
somehow deregulated upon IKAP/hELP1 depletion. Whereas
we indeed noticed that RhoE/Rnd3 protein expression levels
were strongly induced upon actinomycin D stimulation in GFP
shRNAHCT116 cells (Fig. 5, top panels, compare lanes 2–4with
lane 1), Elongator deficiency did not alter basal levels of RhoE/
Rnd3 (Fig. 5, top panel, compare lane 1 with lanes 5 and 9).
Moreover, IKAP/hELP1 depletion did not interfere with the
inducible RhoE/Rnd3 protein expression upon actinomycin DD (20 nM) for the indicated periods of time. Primers were
te on both the SGK and p21 genes, as explained above. The
was set to 1 and its levels in the other conditions were
he figure shows the data from three independent
esW S.D.).
Fig. 6 – Elongator deficiency triggers enhanced BAX expression in HCT116 cells but does not modulate sensitivity to
actinomycin D-mediated apoptosis. (A) IKAP/hELP1 depleted cells show enhanced expression of SGK and BAX but not p21
at the mRNA level. Stably transduced shRNA GFP or IKAP infected HCT116 cells were left untreated or stimulated with
actinomycin D (20 nM) for 2 h and the resulting total RNAs were subjected to quantitative real-time PCR in order to assess
SGK, p21 and BAX mRNA levels, using the appropriate primers. The data are represented as described before. The figure
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12with lanes 2–4). Thus, this result suggests that some but not
all pro-survival p53-dependent genes are regulated by Elon-
gator.
3.3. Elongator deficiency does not significantly modulate
the DNA damage-mediated apoptotic pathway in HCT116
cells
SGK is a pro-survival factor [35] but it was unclear whether its
enhanced expression modulates the apoptotic response of
IKAP/hELP1 depleted cells to DNA-damaging agent. Impor-
tantly and in contrast to p21, both mRNA and protein levels of
BAX were enhanced upon IKAP/hELP1 depletion (Fig. 6A,
middle and right panel, respectively and Fig. 6B, third panel
from the top, compare lane 1 with lanes 4 and 7). Thus, two
distinct p53 target genes coding for proteins acting as a
survival (SGK) or as a pro-apoptotic product (BAX) have
deregulated expression upon Elongator deficient HCT116 cells.
To determine what the resulting outcome is in term of
sensitivity to DNA damage-induced apoptosis, we assessed
PARP and caspase 3 cleavages in IKAP/hELP1 shRNA versus
GFP shRNAHCT116 cells upon stimulationwith actinomycinD
through Western blot analysis. In agreement with previous
reports [36,37], actinomycin D triggered p53 stabilization,
caspase 3 activation and PARP cleavage (Fig. 6B, fourth, first
and second panel from the top, respectively, compare lane 1
with lanes 2 and 3). IKAP/hELP1 depletion did not significantly
modulate caspase 3 activation nor PARP cleavage in response
to actinomycin D (Fig. 6B, top and second panel from the top,
compare lanes 2 and 3 with lanes 5 and 6 and with lanes 8 and
9). In agreement with those results, caspase 3 activities
quantified by means of luminescent-based assays was indeed
induced upon actinomycin D treatment but not affected by the
IKAP/hELP1 depletion in HCT116 cells (Fig. 6C). Indeed, a
modulation of caspase 3 activity upon 48 h of stimulation was
only detected upon infection with one but not the other IKAP
shRNA construct. As caspase 3 activation is intimately linked
to cell apoptosis, we also noticed that IKAP/hELP1 depletion
did not significantly modulate cell viability in actinomycin D
versus untreated HCT116 cells (Fig. 6D). Taken together, our
data demonstrate that Elongator deficiency triggers theshows the data from three independent experiments performed
(B) Enhanced basal but not actinomycin D-induced BAX protein
cells. HCT116 cells were infected with the pLL3.7 shRNA GFP, IKA
infected cells were left untreated or stimulated with actinomyc
extracts were subjected to anti-IKAP/hELP1, -p53, -BAX, -caspa
Elongator deficiency does not modulate actinomycin D-induced c
GFP, IKAP 1 [11] or the IKAP 2 lentiviral construct were seeded
actinomycin D (20 nM) for the indicated periods of time. Cellula
activities. The figure shows the data obtained from three distin
analysis of the data was performed by the one-way ANOVA wi
Software (Graph pad, San Diego, USA). P values <0.05 were cons
does not alter viability nor actinomycin D-induced cell death in
pLL3.7 shRNA GFP, IKAP 1 [11] or the IKAP 2 lentiviral construct
with actinomycin D (20 nM) for the indicated periods of time. V
compared to the one obtained with the untreated HCT116 shRN
data obtained from three distinct lentiviral infections (mean vaactivation of some but not all p53-dependent genes harbour-
ing opposite functions with respect to apoptosis in colon-
derived cancer cells, which most likely explain why IKAP/
hELP1 depletion does not modulate the sensitivity of those
cells to DNA-damaging agents.4. Discussion
We demonstrate here that Elongator deficiency triggers the
activation of selected p53-dependent genes in colon cancer-
derived cells, as evidenced by enhanced expression of BAX and
SGK among other candidates. Moreover, we provide evidence
that IKAP/hELP1 depletion does not significantly sensitize
these cells to apoptosis triggered by a DNA-damaging agent.
Therefore, we propose that the functional integrity of this
complex is required to avoid inappropriate expression of some
p53-dependent genes.
The molecular defects underlying impaired Elongator
function only start to be elucidated. We show here that
IKAP/hELP1 depletion have multiple consequences on the
expression of several but not all p53-dependent genes. Indeed,
IKAP/hELP1 depletion does not affect basal and DNA damage-
induced p21 and BTG2 expression levels. Because both proteins
play critical roles for the p53-mediated cell cycle arrest [38],
this observation suggests that Elongator is dispensable for this
process. This conclusion is further supported by the fact that
progression through the cell cycle does not appear to be
altered upon Elongator deficiency (data not shown). Never-
theless, this issue deserves to be further investigated once
totally deficient IKAP/hELP1 cells will be available, as we
cannot rule out the possibility that residual IKAP/hELP1 levels
seen in our experimental models may be sufficient to ensure
proper progression through the cell cycle.
Elongator deficiency does not significantly affect the
apoptotic status of the HCT116 cells subjected to a DNA-
damaging agent but clearly triggers enhanced expression of
selected p53-dependent genes. It is currently unclear whether
this observation is exclusively due to impaired transcriptional
elongation of selected target genes and/or to altered tRNA
modifications and consequently to impaired translation of
critical proteins. In any case, emerging data seem to indicatefrom two distinct lentiviral infections (mean valuesW S.D.).
levels upon IKAP/hELP1 depletion in colon cancer-derived
P 1 [11] or the IKAP 2 lentiviral construct and the resulting
in D (20 nM) for the indicated periods of time. Protein cell
se 3, -PARP and -a-tubulin Western blot analysis. (C)
ell apoptosis. HCT116 cells infected with the pLL3.7 shRNA
in duplicates and left untreated or stimulated with
r apoptosis was quantified by assessing caspases 3/7
ct lentiviral infections (mean valuesW S.D.). Statistical
th Dunn’s multiple comparison test using the Prism 4.00
idered as statistically significant. (D) IKAP/hELP1 depletion
colon cancer-derived cells. HCT116 cells infected with the
were seeded in duplicates and left untreated or stimulated
iable cells were counted and the resulting number was
A GFP cells as indicated in Section 2. The figure shows the
luesW S.D.).
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response. Regarding transcriptional elongation, previous
reports established a link between inhibition of transcription
and induction of a p53-dependent cellular response [37,39,40].
Whereas these data were obtained using inhibitors of RNA
synthesis such as actinomycin D [39], recent reports based on
the generation of knock-out mice, undoubtedly provided
further evidence for a link between impaired RNA synthesis
and p53 activation. In this context, the in vivo invalidation of
Elongin A, the transcriptionally active form of the elongation
factor Elongin, is embryonic lethal because of senescence-like
growth defects and massive apoptosis. Interestingly, the
Elongin deficient embryos showed activation of the p53
signalling pathways [41]. The blockage of transcriptional
elongation through micro-injection of antibodies that speci-
fically recognized the elongating form of RNA polymerase II
resulted in p53 accumulation in the nucleus, even in the
absence of any DNA damage [40]. We did not observe a
significant p53 accumulation upon Elongator deficiency in
HCT116 cells but this is most likely due to the fact that only a
limited number of genes are not properly transcribed upon
Elongator deficiency [11]. Whether the enhanced p53-depen-
dent gene expression seen upon IKAP/hELP1 depletion is due
to slightly enhanced p53 levels seen in these cells is a likely
explanation. Thus, our study, combined with these reports,
collectively suggest that impaired transcriptional elongation
triggers some p53-dependent pathways.
Because of accumulated evidence for a role of Elongator in
tRNAmodification [14], the activation of some p53-dependent
genes seen upon IKAP/hELP1 depletion may also be due to
impaired tRNA modifications and consequently to transla-
tional infidelity of yet to be identified proteins. In this context,
an impaired ribosome function through conditional knock-out
of the 40S ribosomal protein S6 in T cells triggered defects in
the fidelity of the translational machinery and consequently
activated some p53-dependent checkpoint pathways to pre-
vent aberrant cell division [42]. Which proteins would not be
properly translated because of defects in tRNA modifications
upon Elongator deficiency and how translational infidelity
triggers selected p53 pathways remain unclear issues.
Elongator deficiency causes enhancedmRNA expression of
candidates coding for proteins having opposite functions with
respect to cell survival, such as BAX and SGK for example. This
may explain why the enhanced BAX levels seen in IKAP/hELP1
depleted cells do not trigger more spontaneous apoptosis,
despite the essential role played by this protein in the p53-
mediated pro-apoptotic pathway [43]. Of note however and in
contrast to BAX, we failed to see enhanced SGK expression at
the protein level upon IKAP/hELP1 depletion (data not shown).
This may be due to the intrinsic instability of SGK, which is
known to be quickly degraded through the proteasome
pathway [44]. In any case, we clearly show here that the
upregulated SGK mRNA expression requires wild type p53 as
SGK is no longer induced in p53 deficient HCT116 or in HT29
cells, where p53 is not functional. SGK was previously
identified as a p53-inducible kinase upon DNA damage [45].
Although a potential p53-responsive sequence was found in
the SGK promoter, we have no evidence for p53 being recruited
to this sequence in vivo, as judged by ChIP analysis. We
actually do not support the hypothesis that enhanced SGKexpression seen upon Elongator deficiency occurs at the
transcriptional initiation step as the recruitment of the RNA
polymerase II on the TATA box was not significantly
modulated upon IKAP/hELP1 depletion in HCT116 cells. Thus,
other mechanisms such as a more efficient transcriptional
elongation or a stabilization of the SGK transcript may
underlie SGK upregulation.
Although induced by the pro-apoptotic protein p53, SGK
acts as a pro-survival factor through phosphorylation of
FOXO3a [35]. Thus, this p53-dependent SGK induction can be
seen as compensatory mechanism, as previously reported for
other p53-dependent genes coding for pro-survival candidates
such as COX-2, for example [46,47]. This negative feedback
loopmay also explainwhy the Elongator deficient cells are not
significantly more sensitive to the DNA-damaging-mediated
apoptotic pathway.
We previously reported that IKAP/hELP1 depletion in HeLa
cells triggers the upregulation of some genes, many of which
encoding proteins involved in amino acid metabolism [11].
Such conclusion was also raised based on micro-array
analysis performed on strains with deletions of several
subunits of the Elongator complex in S. cerevisiae [48].
Importantly, this later study also reported that Elongator
deficiency in this experimental system also triggers the
upregulation of a subset of genes known to be induced upon
unfavorable, stressful conditions, such as growth in the
presence of carcinogenic alkylating or oxidizing agents or
when subjected to ionizing radiation [48]. As those agents and
radiations are strong p53-inducers in mammalian cells, our
data suggest that Elongator depletion ultimately induces the
upregulation of stress-induced genes in yeast but also in
mammalian cells, which might underlie a highly conserved
molecular mechanism throughout evolution.
Elongator deficiency is linked to FD, a severe human neuro-
developmental and neurodegenerative genetic disorder [48].
The molecular defects underlying this disease only start to be
uncovered and we previously suggested that cell motility
defects of progenitor neural cells during embryogenesis may
contribute to the observed phenotype of the FD patients [11].
The neurodegeneration seen in this disease most likely
implies premature or enhanced cell death. To which extent
p53 is involved in this process remains totally unknown. Our
present report opens the possibility that the progression of FD
to a neurodegenerative disease may also be caused by a
deregulated activation of some p53-dependent genes.
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